These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34586640)

  • 1. Clinical biomarkers in soft tissue sarcoma A comprehensive review of current soft tissue sarcoma biomarkers.
    Sharma SR; Paonessa NE; Casadei L; Costas De Faria F; Pollock RE; Grignol V
    J Surg Oncol; 2022 Feb; 125(2):239-245. PubMed ID: 34586640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free DNA in blood as a noninvasive insight into the sarcoma genome.
    Namløs HM; Boye K; Meza-Zepeda LA
    Mol Aspects Med; 2020 Apr; 72():100827. PubMed ID: 31703948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized Mini-Panel Sequencing of ctDNA Allows Tumor Monitoring in Complex Karyotype Sarcomas.
    Braig D; Runkel A; Eisenhardt AE; Schmid A; Zeller J; Pauli T; Lausch U; Wehrle J; Bronsert P; Jung M; Kiefer J; Boerries M; Eisenhardt SU
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers.
    Fujiwara T; Kunisada T; Takeda K; Uotani K; Yoshida A; Ochiya T; Ozaki T
    Biomed Res Int; 2014; 2014():592868. PubMed ID: 25165708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes in sarcomas: Tiny messengers with broad implications in diagnosis, surveillance, prognosis and treatment.
    Masaoutis C; Korkolopoulou P; Theocharis S
    Cancer Lett; 2019 May; 449():172-177. PubMed ID: 30779943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactivity of p53, Mdm2, p21(WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with histologic grade.
    Sabah M; Cummins R; Leader M; Kay E
    Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):64-9. PubMed ID: 17536310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Circulating Nucleic Acid Characteristics of Non-Metastatic Soft Tissue Sarcoma Patients.
    Eastley N; Sommer A; Ottolini B; Neumann R; Luo JL; Hastings RK; McCulloch T; Esler CP; Shaw JA; Ashford RU; Royle NJ
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ analysis of soft tissue tumor associated genetic alterations in formalin-fixed paraffin-embedded tissue.
    Horn H; Allmanritter J; Doglioni C; Marx A; Müller J; Gattenlöhner S; Staiger AM; Rosenwald A; Ott G; Ott MM
    Pathol Res Pract; 2014 Dec; 210(12):804-11. PubMed ID: 25446247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.
    Smolle MA; Leithner A; Posch F; Szkandera J; Liegl-Atzwanger B; Pichler M
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNAs and Soft Tissue Sarcomas.
    Fujiwara T; Kunisada T; Takeda K; Ozaki T
    Adv Exp Med Biol; 2015; 889():179-99. PubMed ID: 26659002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing biomarkers for soft tissue sarcomas.
    Czarnecka AM; Chmiel P; Błoński P; Rutkowski P
    Expert Rev Anticancer Ther; 2024 Jun; 24(6):407-421. PubMed ID: 38682679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes.
    Asano N; Matsuzaki J; Ichikawa M; Kawauchi J; Takizawa S; Aoki Y; Sakamoto H; Yoshida A; Kobayashi E; Tanzawa Y; Nakayama R; Morioka H; Matsumoto M; Nakamura M; Kondo T; Kato K; Tsuchiya N; Kawai A; Ochiya T
    Nat Commun; 2019 Mar; 10(1):1299. PubMed ID: 30898996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas.
    Yao X; Ghert M; Dickson BC; Popovic S; Purgina BM; Verma S; Werier J; Kandel RA
    Cancer Treat Rev; 2020 Apr; 85():101987. PubMed ID: 32092619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
    Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
    Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel candidate circulating biomarkers for malignant soft tissue sarcomas: Correlation with metastatic progression.
    Conti A; Fredolini C; Tamburro D; Magagnoli G; Zhou W; Liotta LA; Picci P; Luchini A; Benassi MS
    Proteomics; 2016 Feb; 16(4):689-97. PubMed ID: 26699407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas.
    Braig D; Becherer C; Bickert C; Braig M; Claus R; Eisenhardt AE; Heinz J; Scholber J; Herget GW; Bronsert P; Fricke A; Follo M; Stark GB; Bannasch H; Eisenhardt SU
    Int J Cancer; 2019 Aug; 145(4):1148-1161. PubMed ID: 30779112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doing more with less: New markers for sarcoma diagnosis and their applicability to cytology specimens.
    Dodd LG; Ware P; Duncan D; Hertel J
    Diagn Cytopathol; 2016 Apr; 44(4):351-60. PubMed ID: 26780171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.
    Ito M; Barys L; O'Reilly T; Young S; Gorbatcheva B; Monahan J; Zumstein-Mecker S; Choong PF; Dickinson I; Crowe P; Hemmings C; Desai J; Thomas DM; Lisztwan J
    Clin Cancer Res; 2011 Feb; 17(3):416-26. PubMed ID: 21159888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.